Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Completed 14Unknown 4Terminated 2Active not recruiting 2Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Carcinoma, Non-Small-Cell Lung 56Squamous Cell Carcinoma of Head and Neck 31Lung Neoplasms 17Head and Neck Neoplasms 17Urinary Bladder Neoplasms 16Oropharyngeal Neoplasms 14Nasopharyngeal Carcinoma 11Parkinson Disease 4, Autosomal Dominant Lewy Body 10Carcinoma 10Small Cell Lung Carcinoma 9Carcinoma, Squamous Cell 9Uterine Cervical Neoplasms 8Pancreatic Neoplasms 8Ovarian Neoplasms 8Carcinoma, Transitional Cell 8Neoplasm Metastasis 7Mouth Neoplasms 7Breast Neoplasms 7Triple Negative Breast Neoplasms 6Recurrence 6Neoplasms 6Melanoma 6Gallbladder Neoplasms 6Esophageal Squamous Cell Carcinoma 6Esophageal Neoplasms 6Colorectal Neoplasms 6Biliary Tract Neoplasms 6Mesothelioma, Malignant 5Medulloblastoma 5Laryngeal Neoplasms 5

Interventions

Carboplatin 3Cisplatin 2veliparib 1Watchful Waiting 1Tomography, X-Ray Computed 1Taxes 1Psychiatric Nursing 1Physical Therapy Modalities 1Paclitaxel 1Magnetic Resonance Spectroscopy 1Fluorodeoxyglucose F18 1FAPI-46 1Etoposide 1Educational Status 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Active not recruiting × Testicular Neoplasms × Cisplatin × Clear all
NCT03937843 2026-01-20

Reduced Intensity Radio-chemotherapy for Stage IIA/B Seminoma

Swiss Cancer Institute

Phase 2 Active not recruiting
135 enrolled
Genitourinary

Testicular Neoplasms, Seminoma

NCT02341989 2025-12-02

SWENOTECA-ABC

St. Olavs Hospital

Phase 3 Active not recruiting
348 enrolled
Genitourinary

Recurrence, Testicular Neoplasms, Seminoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡